Research Analysts’ price target changes for Tuesday, November 18th:
Acumen Pharmaceuticals (NASDAQ:ABOS) had its price target trimmed by Bank of America Corporation from $9.00 to $8.00. Bank of America Corporation currently has a buy rating on the stock.
Acadia Healthcare (NASDAQ:ACHC) had its price target reduced by KeyCorp from $35.00 to $30.00. The firm currently has an overweight rating on the stock.
American Integrity Insurance Group (NYSE:AII) had its target price boosted by Keefe, Bruyette & Woods from $26.00 to $29.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
Amgen (NASDAQ:AMGN) had its price target boosted by Daiwa Capital Markets from $310.00 to $370.00. They currently have an outperform rating on the stock.
Amazon.com (NASDAQ:AMZN) had its price target boosted by Loop Capital from $300.00 to $360.00. The firm currently has a buy rating on the stock.
APA (NASDAQ:APA) had its price target raised by Piper Sandler from $22.00 to $23.00. Piper Sandler currently has a neutral rating on the stock.
Ardent Health (NYSE:ARDT) had its price target trimmed by Guggenheim from $18.00 to $15.00. The firm currently has a buy rating on the stock.
Ardent Health (NYSE:ARDT) had its target price lowered by Mizuho from $20.00 to $13.00. Mizuho currently has an outperform rating on the stock.
Aramark (NYSE:ARMK) had its price target cut by Robert W. Baird from $47.00 to $46.00. Robert W. Baird currently has an outperform rating on the stock.
Aramark (NYSE:ARMK) had its target price lowered by Morgan Stanley from $44.00 to $43.00. Morgan Stanley currently has an equal weight rating on the stock.
Biohaven (NYSE:BHVN) had its price target lowered by Morgan Stanley from $54.00 to $26.00. Morgan Stanley currently has an overweight rating on the stock.
Bilibili (NASDAQ:BILI) had its price target increased by JPMorgan Chase & Co. from $24.00 to $27.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Bullish (NYSE:BLSH) had its price target trimmed by JPMorgan Chase & Co. from $63.00 to $46.00. The firm currently has a neutral rating on the stock.
BRT Apartments (NYSE:BRT) had its target price trimmed by Citizens Jmp from $24.00 to $20.00. Citizens Jmp currently has a market outperform rating on the stock.
Perspective Therapeutics (NYSEAMERICAN:CATX) had its price target lowered by B. Riley from $12.00 to $11.00. B. Riley currently has a buy rating on the stock.
Codere Online Luxembourg (NASDAQ:CDRO) had its price target reduced by Stifel Nicolaus from $10.00 to $9.00. The firm currently has a buy rating on the stock.
Choice Hotels International (NYSE:CHH) had its price target trimmed by Robert W. Baird from $122.00 to $110.00. Robert W. Baird currently has an outperform rating on the stock.
Chord Energy (NASDAQ:CHRD) had its price target lowered by Piper Sandler from $167.00 to $165.00. They currently have an overweight rating on the stock.
Comcast (NASDAQ:CMCSA) had its target price lowered by Daiwa Capital Markets from $38.00 to $30.00. The firm currently has an outperform rating on the stock.
Centessa Pharmaceuticals (NASDAQ:CNTA) had its price target boosted by Guggenheim from $28.00 to $43.00. The firm currently has a buy rating on the stock.
Vita Coco (NASDAQ:COCO) had its price target increased by The Goldman Sachs Group, Inc. from $52.00 to $58.00. They currently have a buy rating on the stock.
Crescent Energy (NYSE:CRGY) had its price target trimmed by Piper Sandler from $15.00 to $13.00. They currently have an overweight rating on the stock.
Comstock Resources (NYSE:CRK) had its price target trimmed by Piper Sandler from $9.00 to $8.00. The firm currently has an underweight rating on the stock.
CrowdStrike (NASDAQ:CRWD) had its price target raised by Capital One Financial Corporation from $519.00 to $599.00. Capital One Financial Corporation currently has an overweight rating on the stock.
CrowdStrike (NASDAQ:CRWD) had its price target raised by Rosenblatt Securities from $550.00 to $630.00. Rosenblatt Securities currently has a buy rating on the stock.
CrowdStrike (NASDAQ:CRWD) had its price target raised by Truist Financial Corporation from $550.00 to $600.00. The firm currently has a buy rating on the stock.
Coterra Energy (NYSE:CTRA) had its price target lowered by Piper Sandler from $38.00 to $37.00. Piper Sandler currently has an overweight rating on the stock.
DuPont de Nemours (NYSE:DD) had its price target trimmed by Royal Bank Of Canada from $100.00 to $48.00. The firm currently has an outperform rating on the stock.
Devon Energy (NYSE:DVN) had its price target reduced by Piper Sandler from $57.00 to $55.00. The firm currently has an overweight rating on the stock.
Electra Battery Materials (NASDAQ:ELBM) had its price target reduced by HC Wainwright from $2.20 to $2.10. They currently have a buy rating on the stock.
Eledon Pharmaceuticals (NASDAQ:ELDN) had its price target cut by Guggenheim from $9.00 to $8.00. They currently have a buy rating on the stock.
EOG Resources (NYSE:EOG) had its target price reduced by Piper Sandler from $129.00 to $124.00. Piper Sandler currently has a neutral rating on the stock.
Edgewell Personal Care (NYSE:EPC) had its target price trimmed by Morgan Stanley from $23.00 to $21.00. They currently have an equal weight rating on the stock.
EPR Properties (NYSE:EPR) had its target price raised by Truist Financial Corporation from $55.00 to $57.00. They currently have a hold rating on the stock.
Equinix (NASDAQ:EQIX) had its target price raised by Truist Financial Corporation from $961.00 to $973.00. Truist Financial Corporation currently has a buy rating on the stock.
EQT (NYSE:EQT) had its price target increased by Piper Sandler from $49.00 to $50.00. They currently have a neutral rating on the stock.
Expand Energy (NASDAQ:EXE) had its target price increased by Piper Sandler from $136.00 to $138.00. The firm currently has an overweight rating on the stock.
National Vision (NASDAQ:EYE) had its price target raised by Barclays PLC from $28.00 to $30.00. Barclays PLC currently has an overweight rating on the stock.
National Vision (NASDAQ:EYE) had its price target boosted by Citigroup Inc. from $29.00 to $35.00. They currently have a buy rating on the stock.
Diamondback Energy (NASDAQ:FANG) had its price target trimmed by Piper Sandler from $222.00 to $219.00. They currently have an overweight rating on the stock.
Figure Technology Solutions (NASDAQ:FIGR) had its target price boosted by Keefe, Bruyette & Woods from $48.50 to $52.00. They currently have an outperform rating on the stock.
BitFuFu (NASDAQ:FUFU) had its target price trimmed by B. Riley from $7.00 to $6.00. They currently have a buy rating on the stock.
Genuit Group (LON:GEN) had its target price lowered by Berenberg Bank from GBX 540 to GBX 500. The firm currently has a buy rating on the stock.
Halozyme Therapeutics (NASDAQ:HALO) had its target price increased by The Goldman Sachs Group, Inc. from $54.00 to $56.00. The firm currently has a neutral rating on the stock.
HA Sustainable Infrastructure Capital (NYSE:HASI) had its price target raised by Jefferies Financial Group Inc. from $35.00 to $39.00. The firm currently has a buy rating on the stock.
HIVE Digital Technologies (NASDAQ:HIVE) had its price target raised by HC Wainwright from $8.00 to $10.00. HC Wainwright currently has a buy rating on the stock.
Werewolf Therapeutics (NASDAQ:HOWL) had its target price trimmed by Bank of America Corporation from $8.00 to $7.00. The firm currently has a buy rating on the stock.
H World Group (NASDAQ:HTHT) had its price target increased by Benchmark Co. from $48.00 to $52.00. Benchmark Co. currently has a buy rating on the stock.
Immatics (NASDAQ:IMTX) had its price target increased by Guggenheim from $16.00 to $19.00. Guggenheim currently has a buy rating on the stock.
Invitation Home (NYSE:INVH) had its target price reduced by JPMorgan Chase & Co. from $38.00 to $37.00. They currently have an overweight rating on the stock.
Inventiva (NASDAQ:IVA) had its target price lowered by Guggenheim from $13.00 to $11.00. The firm currently has a buy rating on the stock.
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price target increased by Bank of America Corporation from $230.00 to $247.00. Bank of America Corporation currently has a buy rating on the stock.
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its target price increased by Robert W. Baird from $160.00 to $209.00. They currently have an outperform rating on the stock.
Jade Biosciences (NASDAQ:JBIO) had its price target raised by Guggenheim from $14.00 to $17.00. The firm currently has a buy rating on the stock.
J & J Snack Foods (NASDAQ:JJSF) had its target price reduced by Benchmark Co. from $150.00 to $130.00. They currently have a buy rating on the stock.
Kingfisher (LON:KGF) had its price target raised by Deutsche Bank Aktiengesellschaft from GBX 280 to GBX 285. Deutsche Bank Aktiengesellschaft currently has a hold rating on the stock.
Kodiak Gas Services (NYSE:KGS) had its price target increased by Royal Bank Of Canada from $43.00 to $45.00. They currently have an outperform rating on the stock.
Klarna Group (NYSE:KLAR) had its price target lowered by Bank of America Corporation from $51.00 to $46.00. Bank of America Corporation currently has a buy rating on the stock.
LifeMD (NASDAQ:LFMD) had its price target cut by B. Riley from $12.00 to $10.00. They currently have a buy rating on the stock.
LifeMD (NASDAQ:LFMD) had its target price lowered by Lake Street Capital from $14.00 to $8.00. They currently have a buy rating on the stock.
LifeMD (NASDAQ:LFMD) had its price target cut by BTIG Research from $18.00 to $10.00. They currently have a buy rating on the stock.
Lifeward (NASDAQ:LFWD) had its price target lowered by HC Wainwright from $13.00 to $4.50. They currently have a buy rating on the stock.
Eli Lilly and Company (NYSE:LLY) had its price target boosted by JPMorgan Chase & Co. from $1,050.00 to $1,150.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Lyft (NASDAQ:LYFT) had its target price raised by Guggenheim from $24.00 to $26.00. Guggenheim currently has a buy rating on the stock.
Live Nation Entertainment (NYSE:LYV) had its price target lowered by Guggenheim from $175.00 to $172.00. Guggenheim currently has a buy rating on the stock.
Magnolia Oil & Gas (NYSE:MGY) had its price target reduced by Piper Sandler from $25.00 to $23.00. Piper Sandler currently has a neutral rating on the stock.
Merck & Co., Inc. (NYSE:MRK) had its price target increased by Deutsche Bank Aktiengesellschaft from $110.00 to $111.00. Deutsche Bank Aktiengesellschaft currently has a hold rating on the stock.
Marvell Technology (NASDAQ:MRVL) had its price target raised by The Goldman Sachs Group, Inc. from $72.00 to $80.00. The firm currently has a neutral rating on the stock.
National Energy Services Reunited (NASDAQ:NESR) had its target price increased by Piper Sandler from $15.00 to $19.00. They currently have an overweight rating on the stock.
Netflix (NASDAQ:NFLX) had its target price trimmed by Barclays PLC to $110.00. Barclays PLC currently has an equal weight rating on the stock.
Netflix (NASDAQ:NFLX) had its price target trimmed by JPMorgan Chase & Co. from $127.50 to $124.00. They currently have a neutral rating on the stock.
NiCE (NASDAQ:NICE) had its price target lowered by Cantor Fitzgerald from $154.00 to $133.00. They currently have a neutral rating on the stock.
NiCE (NASDAQ:NICE) had its price target reduced by Jefferies Financial Group Inc. from $152.00 to $136.00. The firm currently has a hold rating on the stock.
NiCE (NASDAQ:NICE) had its price target reduced by Royal Bank Of Canada from $190.00 to $175.00. The firm currently has an outperform rating on the stock.
NiCE (NASDAQ:NICE) had its price target lowered by Mizuho from $185.00 to $150.00. Mizuho currently has an outperform rating on the stock.
NiCE (NASDAQ:NICE) had its target price cut by Morgan Stanley from $193.00 to $160.00. They currently have an overweight rating on the stock.
NiCE (NASDAQ:NICE) had its target price trimmed by Rosenblatt Securities from $190.00 to $175.00. They currently have a buy rating on the stock.
NET Power (NYSE:NPWR) had its price target trimmed by Citigroup Inc. from $6.00 to $4.00. Citigroup Inc. currently has a buy rating on the stock.
Nuvalent (NASDAQ:NUVL) had its price target increased by The Goldman Sachs Group, Inc. from $120.00 to $135.00. They currently have a buy rating on the stock.
Nuvalent (NASDAQ:NUVL) had its target price increased by Guggenheim from $125.00 to $155.00. They currently have a buy rating on the stock.
Nuvalent (NASDAQ:NUVL) had its price target increased by Robert W. Baird from $112.00 to $158.00. Robert W. Baird currently has an outperform rating on the stock.
Novavax (NASDAQ:NVAX) had its target price trimmed by JPMorgan Chase & Co. from $7.00 to $6.00. They currently have an underweight rating on the stock.
NVIDIA (NASDAQ:NVDA) had its target price raised by BNP Paribas Exane from $240.00 to $250.00. BNP Paribas Exane currently has an outperform rating on the stock.
NVIDIA (NASDAQ:NVDA) had its target price boosted by Stifel Nicolaus from $212.00 to $250.00. Stifel Nicolaus currently has a buy rating on the stock.
ONE Gas (NYSE:OGS) had its price target raised by Mizuho from $86.00 to $87.00. Mizuho currently has an outperform rating on the stock.
Okta (NASDAQ:OKTA) had its target price reduced by Barclays PLC from $112.00 to $95.00. They currently have an equal weight rating on the stock.
Olema Pharmaceuticals (NASDAQ:OLMA) had its target price boosted by JPMorgan Chase & Co. from $29.00 to $32.00. The firm currently has an overweight rating on the stock.
Olema Pharmaceuticals (NASDAQ:OLMA) had its price target boosted by HC Wainwright from $28.00 to $36.00. They currently have a buy rating on the stock.
Olema Pharmaceuticals (NASDAQ:OLMA) had its price target increased by Oppenheimer Holdings, Inc. from $22.00 to $45.00. The firm currently has an outperform rating on the stock.
BeOne Medicines (NASDAQ:ONC) had its target price increased by Royal Bank Of Canada from $395.00 to $408.00. The firm currently has an outperform rating on the stock.
Onto Innovation (NYSE:ONTO) had its price target boosted by B. Riley from $173.00 to $180.00. B. Riley currently has a buy rating on the stock.
Oracle (NYSE:ORCL) had its target price trimmed by Robert W. Baird from $365.00 to $315.00. They currently have an outperform rating on the stock.
Oric Pharmaceuticals (NASDAQ:ORIC) had its price target raised by JPMorgan Chase & Co. from $17.00 to $20.00. They currently have an overweight rating on the stock.
OS Therapies (NYSEAMERICAN:OSTX) had its price target cut by Lake Street Capital from $18.00 to $17.00. They currently have a buy rating on the stock.
Occidental Petroleum (NYSE:OXY) had its target price lowered by Piper Sandler from $47.00 to $46.00. The firm currently has a neutral rating on the stock.
Palo Alto Networks (NASDAQ:PANW) had its target price increased by Rosenblatt Securities from $225.00 to $250.00. They currently have a buy rating on the stock.
Phillips Edison & Company, Inc. (NASDAQ:PECO) had its target price boosted by Barclays PLC from $38.00 to $40.00. They currently have an equal weight rating on the stock.
Phunware (NASDAQ:PHUN) had its price target trimmed by HC Wainwright from $3.00 to $2.00. HC Wainwright currently has a neutral rating on the stock.
Promis Neurosciences (NASDAQ:PMN) had its target price trimmed by Guggenheim from $6.00 to $5.00. Guggenheim currently has a buy rating on the stock.
Permian Resources (NYSE:PR) had its price target cut by Piper Sandler from $21.00 to $20.00. The firm currently has an overweight rating on the stock.
Rocket Pharmaceuticals (NASDAQ:RCKT) had its price target trimmed by Bank of America Corporation from $10.00 to $8.00. They currently have a buy rating on the stock.
Regency Centers (NASDAQ:REG) had its target price lowered by Truist Financial Corporation from $81.00 to $77.00. The firm currently has a buy rating on the stock.
Royal Gold (NASDAQ:RGLD) (TSE:RGL) had its target price increased by TD Cowen from $261.00 to $263.00. They currently have a buy rating on the stock.
Range Resources (NYSE:RRC) had its price target cut by Piper Sandler from $39.00 to $37.00. Piper Sandler currently has a neutral rating on the stock.
Sharplink Gaming (NASDAQ:SBET) had its target price cut by B. Riley from $32.00 to $19.00. They currently have a buy rating on the stock.
Tanger (NYSE:SKT) had its price target raised by Barclays PLC from $35.00 to $37.00. Barclays PLC currently has an equal weight rating on the stock.
SLR Investment (NASDAQ:SLRC) had its price target trimmed by Keefe, Bruyette & Woods from $17.00 to $16.50. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
Semtech (NASDAQ:SMTC) had its target price boosted by Susquehanna from $65.00 to $80.00. Susquehanna currently has a positive rating on the stock.
Simon Property Group (NYSE:SPG) had its target price raised by Barclays PLC from $180.00 to $186.00. Barclays PLC currently has an equal weight rating on the stock.
Spire (NYSE:SR) had its price target raised by Morgan Stanley from $91.00 to $99.00. The firm currently has an equal weight rating on the stock.
Scholar Rock (NASDAQ:SRRK) had its target price boosted by JPMorgan Chase & Co. from $46.00 to $47.00. The firm currently has an overweight rating on the stock.
Sun Communities (NYSE:SUI) had its price target increased by Truist Financial Corporation from $141.00 to $142.00. The firm currently has a buy rating on the stock.
Trip.com Group (NASDAQ:TCOM) had its target price raised by Benchmark Co. from $80.00 to $82.00. They currently have a buy rating on the stock.
Atlassian (NASDAQ:TEAM) had its target price raised by Sanford C. Bernstein from $290.00 to $304.00. Sanford C. Bernstein currently has an outperform rating on the stock.
TELA Bio (NASDAQ:TELA) had its target price lowered by Canaccord Genuity Group Inc. from $7.00 to $4.00. They currently have a buy rating on the stock.
Terns Pharmaceuticals (NASDAQ:TERN) had its price target boosted by BMO Capital Markets from $22.00 to $30.00. The firm currently has an outperform rating on the stock.
Tango Therapeutics (NASDAQ:TNGX) had its price target boosted by B. Riley from $8.00 to $14.00. The firm currently has a buy rating on the stock.
Targa Resources (NYSE:TRGP) had its price target raised by Royal Bank Of Canada from $208.00 to $213.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Trupanion (NASDAQ:TRUP) had its price target reduced by Stifel Nicolaus from $45.00 to $42.00. They currently have a hold rating on the stock.
Trivago N.V. ADS (NASDAQ:TRVG) had its price target cut by Citigroup Inc. from $3.80 to $3.35. They currently have a neutral rating on the stock.
V.F. (NYSE:VFC) had its price target increased by The Goldman Sachs Group, Inc. from $15.00 to $16.00. The Goldman Sachs Group, Inc. currently has a neutral rating on the stock.
Vista Energy (NYSE:VIST) had its target price boosted by Bank of America Corporation from $63.00 to $90.00. Bank of America Corporation currently has a buy rating on the stock.
Viper Energy (NASDAQ:VNOM) had its price target lowered by Piper Sandler from $68.00 to $64.00. The firm currently has an overweight rating on the stock.
Vital Energy (NYSE:VTLE) had its target price cut by Piper Sandler from $30.00 to $25.00. They currently have a neutral rating on the stock.
Whitestone REIT (NYSE:WSR) had its target price increased by Truist Financial Corporation from $14.00 to $15.00. The firm currently has a buy rating on the stock.
Xenon Pharmaceuticals (NASDAQ:XENE) had its price target increased by JPMorgan Chase & Co. from $57.00 to $60.00. The firm currently has an overweight rating on the stock.
Zscaler (NASDAQ:ZS) had its target price increased by Rosenblatt Securities from $330.00 to $365.00. Rosenblatt Securities currently has a buy rating on the stock.
Zoetis (NYSE:ZTS) had its price target cut by Stifel Nicolaus from $140.00 to $130.00. They currently have a hold rating on the stock.
Zymeworks (NYSE:ZYME) had its price target raised by HC Wainwright from $26.00 to $32.00. HC Wainwright currently has a buy rating on the stock.
Receive News & Ratings for Acumen Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acumen Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.
